Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

Cancer Res. 2007 May 15;67(10):4545-9. doi: 10.1158/0008-5472.CAN-06-2888.

Abstract

The workshop report, entitled Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint National Cancer Institute's Early Detection Research Network and National Institute of Standards and Technology Workshop, presents a summary of the main issues, current challenges, outcomes, and recommendations toward application of methylated DNA sequences as cancer biomarkers.

Publication types

  • Congress

MeSH terms

  • Biomarkers, Tumor / genetics*
  • DNA Methylation*
  • DNA, Neoplasm / blood
  • DNA, Neoplasm / genetics
  • Humans
  • Neoplasms / blood
  • Neoplasms / diagnosis
  • Neoplasms / genetics*
  • Promoter Regions, Genetic
  • Specimen Handling / methods

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm